Most Popular in:
Medical Beauty Treatments Expected to Gain in Europe
Posted: January 8, 2010
page 2 of 3
"Medicalized beauty treatments can no longer be seen as a pure luxury," Laurent Brones, business development manager at Symatese Biomaterials, a French maker of collagen, told Reuters. "Patients have more options, that's why injections like dermal fillers or botulinum toxin were and are not much affected by the crisis whereas surgery follows the same pattern as durable goods—it's like buying a car, it requires thorough research, time and more money."
Women around the globe are increasingly striving to emphasize their natural beauty and so-called medical spas, not to be confused with beauty resorts, offer a package of therapies performed by doctors and nurses. "Among patients it's increasingly fashionable to want to keep one's facial expressions intact rather than opt for a more drastic change in looks through surgery," plastic surgeon and IMCAS director Benjamin Ascher told Reuters.
Medical spas still have ample room for development in Europe. "Europe lags behind compared to the United States," Ascher said. "The potential is huge."
Demand for so-called light treatments that do not require a recovery at the hospital or at home and have a relatively long-term effect is on the rise at the detriment of costly and time-consuming surgery. That development also means that plastic surgeons are increasingly keeping their scalpels in their boxes. Their expertise is shifting from pure surgery to medical applications. "It's a natural evolution in surgery. If there's a choice between surgery and a medical treatment with both producing the same result, the choice is for the treatment," Ascher told Reuters.
Revenues from breast surgery should recover again, growing between 5–10% annually in the coming years to 2013 from a decline of 15% last year. The worldwide breast implant market is estimated to be worth 500 million euros.